Malaria And Infectious Diseases In The Asia-Pacific: Drugs, Vaccines And Diagnostics
Funder
National Health and Medical Research Council
Funding Amount
$210,873.00
Summary
Dr Karunajeewa is an expert in the treatment of malaria and other infectious diseases that have a major impact on the health of people living in developing countries of the tropical zone of the Asia-Pacific region. His ongoing research aims to develop better ways of diagnosing these infections, defining their relative importance in terms of overall burden of disease, finding optimal drug treatments and testing the effectiveness of new vaccines for their prevention.
Enhancing Anti-parasitic Drug Discovery With Metabolomics
Funder
National Health and Medical Research Council
Funding Amount
$483,402.00
Summary
Tropical diseases, such as malaria, infect millions of people each year, and drug resistance is emerging to current treatments. This research will improve our understanding of how current medicines work, and importantly, identify ways in which potential new drugs can kill malaria parasites.
A Transgenic Approach To Rationale Drug Design In Plasmodium Falciparum
Funder
National Health and Medical Research Council
Funding Amount
$420,872.00
Summary
Malaria is a disease caused by parasites of the genus Plasmodium. It is responsible for more than 2 million deaths per year predominately in Sub-Saharan Africa. Many of the currently used drugs to combat this disease are failing through drug resistance in the parasite population. New and novel drugs are urgently required. This project uses state of the art techniques to identify and validate new and novel targets within the parasite that can be used for rational drug design
The extraordinary virulence of malaria parasites is in part due to their ability to export hundreds of proteins into their host cell to obtain nutrients and avoid the immune system. Recently the investigator has discovered the machinery that provides the gateway for these proteins to enter the host cell. She now aims to characterise this machinery and dissect its functional significance in vivo, so that strategies that block this crucial process can be developed to kill the parasite.
Unravelling Plasmodium Vivax Transmission To Anopheles Mosquitoes: Role Of Naturally Acquired Transmission Blocking Immunity And Efficacy Of Novel Vaccine And Drug Candidates
Funder
National Health and Medical Research Council
Funding Amount
$431,000.00
Summary
This project is aimed at better understanding transmission of P. vivax, the world’s most widely spread malaria parasite. Using a newly established experimental platform that enables us to feed P. vivax infected blood to Anopheles farauti mosquitoes, we can start researching factors in human blood that determine P. vivax infection success, test new vaccine and drug candidates for their ability to block transmission and thus significantly advance science surrounding this neglected parasite.
Understanding Whole Cell Protein Trafficking In Plasmodium Parasites
Funder
National Health and Medical Research Council
Funding Amount
$466,492.00
Summary
I am a molecular biologist and bioinformatician studying the cell biology of human parasites. I have expertise in the bioinformatic analysis of parasite genomes to predict where proteins will reside in cell, how they participate in metabolic pathways, and how they might be suitable as targets for drugs and vaccines to control parasitic diseases. This fellowship will investigate the cell biology of Plasmodium parasites, the causative agents of malaria, using computational and biochemical tools to ....I am a molecular biologist and bioinformatician studying the cell biology of human parasites. I have expertise in the bioinformatic analysis of parasite genomes to predict where proteins will reside in cell, how they participate in metabolic pathways, and how they might be suitable as targets for drugs and vaccines to control parasitic diseases. This fellowship will investigate the cell biology of Plasmodium parasites, the causative agents of malaria, using computational and biochemical tools to characterise drug and vaccine targets.Read moreRead less
Functional Genomics Of Malaria Liver Infection And Transmission
Funder
National Health and Medical Research Council
Funding Amount
$470,144.00
Summary
Chemotherapy is the front line defense against malaria but resistance is emerging. The WHO has advised that new drugs should target parasite stages that perpetuate the transmission of malaria to break the cycle of infection. We have identified proteins that are essential for the two transmissive stages of the most deadly parasite to infect their hosts. We will determine the precise function of these proteins and the mechanisms they govern. This may guide the development of new interventions.
Regulation Of Actin Polymerization During Malaria Parasite Invasion Of The Human Erythrocyte
Funder
National Health and Medical Research Council
Funding Amount
$282,790.00
Summary
Malaria parasites depend on successful invasion of red blood cells for their survival. Invasion is powered by a molecular motor based on two key proteins: actin and myosin. Non-specific drugs that inhibit parasite actin block invasion, demonstrating how important its regulation is to parasite success. This project will study several newly identified malaria actin-regulators, aiming to identify new drug targets that will block malaria actin function, stop motility and as such prevent disease.
Computational Methods For The Analysis Of Next Generation Sequence Data In Human Disease
Funder
National Health and Medical Research Council
Funding Amount
$401,361.00
Summary
Modern DNA sequencing technologies generate data at an unprecedented rate, providing the opportunity to develop deep insights into human disease. We can now sequence a tumour genome in a matter of weeks, or assay epigenetic marks in the malaria parasite genome, but these data raise new analysis challenges requiring new statistical and computational methods to solve. This fellowship will support the development of such new methods and will contribute to basic discoveries in human disease.